1. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, et al. 2001; Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 51:349–364. DOI:
10.3322/canjclin.51.6.349. PMID:
11760569.
Article
3. Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. 2017; Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 23:3978–3998. DOI:
10.3748/wjg.v23.i22.3978. PMID:
28652652. PMCID:
PMC5473118.
Article
5. Yamamoto Y, Sugiura T, Ashida R, Okamura Y, Ito T, Uesaka K. 2017; Indications for major hepatectomy and combined procedures for advanced gallbladder cancer. Br J Surg. 104:257–266. DOI:
10.1002/bjs.10401. PMID:
27864927.
Article
6. Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, et al. 2016; Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced T stage. PLoS One. 11:e0166361. DOI:
10.1371/journal.pone.0166361. PMID:
27846279. PMCID:
PMC5112857.
Article
7. Kuipers H, de Savornin Lohman EAJ, van Dooren M, Braat AE, Daams F, van Dam R, et al. 2021; Extended resections for advanced gallbladder cancer: results from a nationwide cohort study. Ann Surg Oncol. 28:835–843. DOI:
10.1245/s10434-020-08858-z. PMID:
32696306. PMCID:
PMC7801314.
Article
8. Sakamoto Y, Nara S, Kishi Y, Esaki M, Shimada K, Kokudo N, et al. 2013; Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 153:794–800. DOI:
10.1016/j.surg.2012.11.024. PMID:
23415082.
Article
9. D'Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. 2009; Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 16:806–816. DOI:
10.1245/s10434-008-0189-3. PMID:
18985272.
10. Cai ZQ, Guo P, Si SB, Geng ZM, Chen C, Cong LL. 2017; Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network. Sci Rep. 7:293. DOI:
10.1038/s41598-017-00491-3. PMID:
28331235. PMCID:
PMC5428511.
Article
11. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. 2017. AJCC cancer staging manual. 8th ed. Springer;Cham:
12. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. 2009; The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 250:187–196. DOI:
10.1097/SLA.0b013e3181b13ca2. PMID:
19638912.
13. Witjes CD, van den Akker SA, Visser O, Karim-Kos HE, de Vries E, Ijzermans JN, et al. 2012; Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg. 29:92–98. DOI:
10.1159/000336217. PMID:
22441693.
Article
14. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. 2004; Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 11:310–315. DOI:
10.1245/ASO.2004.03.011. PMID:
14993027.
Article
15. Yang XW, Yuan JM, Chen JY, Yang J, Gao QG, Yan XZ, et al. 2014; The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer. 14:652. DOI:
10.1186/1471-2407-14-652. PMID:
25187159. PMCID:
PMC4164789.
Article
16. Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, et al. 2018; Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: a systematic review and meta-analysis. J Surg Oncol. 118:477–485. DOI:
10.1002/jso.25186. PMID:
30259519.
Article
17. Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F, et al. 2011; Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol. 37:505–512. DOI:
10.1016/j.ejso.2011.03.135. PMID:
21514090.
Article
18. Miura F, Asano T, Amano H, Toyota N, Wada K, Kato K, et al. 2010; New prognostic factor influencing long-term survival of patients with advanced gallbladder carcinoma. Surgery. 148:271–277. DOI:
10.1016/j.surg.2010.04.022. PMID:
20570306.
Article
19. Kaneoka Y, Yamaguchi A, Isogai M. 2007; Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg. 14:142–148. DOI:
10.1007/s00534-006-1108-2. PMID:
17384904.
Article
20. Hakeem AR, Papoulas M, Menon KV. 2019; The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - a systematic review. Eur J Surg Oncol. 45:83–91. DOI:
10.1016/j.ejso.2018.08.020. PMID:
30287098.
Article
21. Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. 2019; Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 20:663–673. Erratum in: Lancet Oncol 2019;20:e242.
Article